---
layout: post
title: "Alternative Translation Initiation in PRKN Delays the Onset of Parkinson's Disease and Offers a Therapeutic Target."
date:
author: "Habakuk Hain"
categories: transmission
tags: ["PRKN mutations", "alternative translation", "precision therapy"]
image:
rating: 8
paper_title: "Alternative Translation Initiation in PRKN Delays the Onset of Parkinson's Disease and Offers a Therapeutic Target."
paper_author: "Hach"
paper_journal: "Annals of neurology"
paper_year: "2026"
paper_doi: "https://doi.org/10.1002/ana.78180"
paper_et_al: true
summary: "Patients with homozygous PRKN exon 2 deletions develop Parkinson's disease ~8 years later than those with other PRKN mutations due to production of a truncated but partially functional Parkin protein via alternative translation initiation. This residual protein function can be pharmacologically enhanced with small molecule modulators, offering a genotype-specific therapeutic approach."
author_context: "International collaboration led by Institute of Neurogenetics, University of LÃ¼beck, with expertise in movement disorders genetics and cellular modeling"
---

**Problem**: Why some PRKN mutation carriers have delayed Parkinson's disease onset compared to others with the same gene affected.

**Result**: Exon 2 deletions allow production of a truncated Parkin protein (lacking amino acids 1-79) that retains partial ubiquitin ligase activity and delays disease onset.

**Open Questions**: Whether this genotype-stratified approach with Parkin modulators will prove clinically effective and how to optimize patient selection given the drug's inhibitory effects on wild-type Parkin.
